other
confidence high
sentiment neutral
materiality 0.30
Lixte receives conversion notice for 350,000 Series A Preferred shares into 72,917 common shares
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- Notice received May 16, 2025 for 350,000 Series A Convertible Preferred shares.
- Issued to an investor in 2015 and 2016; converts into 72,917 shares of common stock.
- Conversion dilutes existing common equity by approximately 72,917 shares.